Non-Invasive Ventilation
(NIV) and Aerogen
Glossary
Logo

Aerogen Solo
Summary

The following statements summarise the information that has been covered in this learning module about Aerogen and Non-Invasive Ventilation.

Click each arrow to reveal the next statement

CPAP provides pressure throughout the whole respiratory cycle and is used in hypoxaemia respiratory failure.1

BIPAP creates inspiratory positive airway pressure (IPAP) on inhalation which augments patients' own spontaneous breath and on expirations maintains baseline expiratory positive airway pressure (EPAP) or PEEP. This is used in hypercapnia type 2 respiratory failure.2

Aerogen remains in-line with no added flow and no interruption of therapy during administration of medication.3

In studies, aerosol drug delivery with Aerogen via NIV was associated with ~4x more medication delivered to the lungs compared to jet Nebulizers.†4,‡5

Aerogen supports improvements in patients' symptoms and bronchodilator response. In a study, aerosol drug delivery with Aerogen via NIV was associated with significant improvements in lung function (FEV1, FVC, breathlessness score, RR, and PaCO2) versus jet Nebulizers during acute exacerbations of COPD.§6